Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Breedlove Robert Charles. Insider active across 1 company, notably Phathom Pharmaceuticals, Inc.. In total, 7 disclosures have been recorded. Split: 0 buy · 3 sells. Total volume traded: €23k. History available since 16 July 2025. The latest transaction was disclosed on 14 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
A declarant linked to Phathom Pharmaceuticals, Inc., where he is Principal Accounting Officer. He has 6 filings in total, and across the 6 most recent filings covered here, the activity is mainly sells, with sum_sell_eur of 23084 and sum_buy_eur of 0, between 2025-07-18 and 2026-03-03.